J. Smith, E. Trogan, M. Ginsberg, C. Grigaux, and J. Tian, Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E., Proceedings of the National Academy of Sciences, vol.92, issue.18, pp.8264-8268, 1995.
DOI : 10.1073/pnas.92.18.8264

A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends in Immunology, vol.23, issue.11, pp.549-555, 2002.
DOI : 10.1016/S1471-4906(02)02302-5

M. Munder, K. Eichmann, and M. Modolell, Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype, J Immunol, vol.160, pp.5347-5354, 1998.

J. Shearer, J. Richards, C. Mills, and M. Caldwell, Differential regulation of macrophage arginine metabolism: a proposed role in wound healing, 1997.

M. Nair, D. Cochrane, and J. Allen, Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro, Immunology Letters, vol.85, issue.2, pp.173-180, 2003.
DOI : 10.1016/S0165-2478(02)00225-0

F. Sutterwala, G. Noel, P. Salgame, and D. Mosser, Reversal of Proinflammatory Responses by Ligating the Macrophage Fc?? Receptor Type I, The Journal of Experimental Medicine, vol.135, issue.1, pp.217-222, 1998.
DOI : 10.1172/JCI117837

W. Wang, C. Jenkinson, J. Griscavage, R. Kern, and N. Arabolos, Co-induction of Arginase and Nitric Oxide Synthase in Murine Macrophages Activated by Lipopolysaccharide, Biochemical and Biophysical Research Communications, vol.210, issue.3, pp.1009-1016, 1995.
DOI : 10.1006/bbrc.1995.1757

M. Stein, S. Keshav, N. Harris, and S. Gordon, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, Journal of Experimental Medicine, vol.176, issue.1, pp.287-292, 1992.
DOI : 10.1084/jem.176.1.287

P. Loke, M. Nair, J. Parkinson, D. Guiliano, and M. Blaxter, IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype, BMC Immunology, vol.3, issue.1, p.7, 2002.
DOI : 10.1186/1471-2172-3-7

O. Akbari, P. Stock, E. Meyer, M. Kronenberg, and S. Sidobre, Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity, Nature Medicine, vol.9, issue.5, pp.582-588, 2003.
DOI : 10.1038/nm851

A. Zernecke, I. Bot, Y. Djalali-talab, E. Shagdarsuren, and K. Bidzhekov, Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis, Circulation Research, vol.102, issue.2, pp.209-217, 2008.
DOI : 10.1161/CIRCRESAHA.107.160697

M. Van-leeuwen, M. Gijbels, A. Duijvestijn, M. Smook, and M. Van-de-gaar, Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR / Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.1, pp.84-89, 2008.
DOI : 10.1161/ATVBAHA.107.154807

E. Tupin, A. Nicoletti, R. Elhage, M. Rudling, and H. Ljunggren, CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis, The Journal of Experimental Medicine, vol.9, issue.3, pp.417-422, 2004.
DOI : 10.1038/nm876

J. Odegaard, R. -. Gonzalez, R. Goforth, M. Morel, C. Subramanian et al., Macrophage-specific PPAR?? controls alternative activation and improves insulin resistance, Nature, vol.292, issue.7148, pp.1116-1120, 2007.
DOI : 10.1038/nature05894

M. Ricote, A. Valledor, and C. Glass, Decoding Transcriptional Programs Regulated by PPARs and LXRs in the Macrophage: Effects on Lipid Homeostasis, Inflammation, and Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.2, pp.230-239, 2004.
DOI : 10.1161/01.ATV.0000103951.67680.B1

M. Bouhlel, B. Derudas, E. Rigamonti, R. Dievart, and J. Brozek, PPAR?? Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties, Cell Metabolism, vol.6, issue.2, pp.137-143, 2007.
DOI : 10.1016/j.cmet.2007.06.010

H. Li, C. Meininger, J. Hawker, . Jr, T. Haynes et al., Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells, Am J Physiol Endocrinol Metab, vol.280, pp.75-82, 2001.

F. Porcheray, S. Viaud, A. Rimaniol, C. Leone, and B. Samah, Macrophage activation switching: an asset for the resolution of inflammation, Clinical and Experimental Immunology, vol.72, issue.0, pp.481-489, 2005.
DOI : 10.1159/000028079

R. Stout, C. Jiang, B. Matta, I. Tietzel, and S. Watkins, Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences, The Journal of Immunology, vol.175, issue.1, pp.342-349, 2005.
DOI : 10.4049/jimmunol.175.1.342

R. Stout and J. Suttles, Functional plasticity of macrophages: reversible adaptation to changing microenvironments, Journal of Leukocyte Biology, vol.76, issue.3, pp.509-513, 2004.
DOI : 10.1189/jlb.0504272

M. Modolell, I. Corraliza, F. Link, G. Soler, and K. Eichmann, Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH 1 and TH 2 cytokines, European Journal of Immunology, vol.179, issue.4, pp.1101-1104, 1995.
DOI : 10.1002/eji.1830250436

M. Dupasquier, P. Stoitzner, H. Wan, D. Cerqueira, and A. Van-oudenaren, The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling, Journal of Leukocyte Biology, vol.80, issue.4, pp.838-849, 2006.
DOI : 10.1189/jlb.1005564

E. Kasmi, K. Qualls, J. Pesce, J. Smith, A. Thompson et al., Toll-like receptor???induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens, Nature Immunology, vol.68, issue.12, pp.1399-1406, 2008.
DOI : 10.1038/ni.1671

P. Loke, I. Gallagher, M. Nair, X. Zang, and F. Brombacher, Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection, The Journal of Immunology, vol.179, issue.6, pp.3926-3936, 2007.
DOI : 10.4049/jimmunol.179.6.3926

J. Khallou-laschet, G. Caligiuri, E. Groyer, E. Tupin, and A. Gaston, The Proatherogenic Role of T Cells Requires Cell Division and Is Dependent on the Stage of the Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.2, pp.353-358, 2006.
DOI : 10.1161/01.ATV.0000198401.05221.13

B. Staels, PPAR?? and atherosclerosis, Current Medical Research and Opinion, vol.21, issue.sup1, pp.13-20, 2005.
DOI : 10.1185/030079905X36440

A. Nicoletti, S. Kaveri, G. Caligiuri, J. Bariety, and G. Hansson, Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice., Journal of Clinical Investigation, vol.102, issue.5, pp.910-918, 1998.
DOI : 10.1172/JCI119892

O. Levillain, S. Balvay, and S. Peyrol, Localization and differential expression of arginase II in the kidney of male and female mice, Pfl???gers Archiv - European Journal of Physiology, vol.30, issue.5, pp.491-503, 2005.
DOI : 10.1007/s00424-004-1336-8

M. Pfaffl, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Research, vol.29, issue.9, p.45, 2001.
DOI : 10.1093/nar/29.9.e45

J. Ray, R. Leach, J. Herbert, and M. Benson, Isolation of vascular smooth muscle cells from a single murine aorta, Methods Cell Sci, vol.23, pp.185-188, 2001.

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983.
DOI : 10.1016/0022-1759(83)90303-4